Scientists have unveiled a new fabrication technique for the ultra-clean manufacturing of 2D heterostructures—materials just ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Sixtyfour CEO Saarth Shah explains how his company built AI research agents around rigorous evaluation systems rather than language model fluency, creating verification infrastructure that proves ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...

Researchers developed a new chip stacking method that could quadruple AI memory density, potentially solving one of the biggest hardware bottlenecks slowing AI down today.

On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...

It's an upgrade worth making, but it comes down to your privacy concerns.

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their financials and risk profiles stack up?

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...

OpenAI says two employees' devices were breached in the recent TanStack supply chain attack that impacted hundreds of npm and PyPI packages, causing the company to rotate code-signing certificates for ...